Year |
Citation |
Score |
2024 |
Trickey A, McGinnis K, Gill MJ, Abgrall S, Berenguer J, Wyen C, Hessamfar M, Reiss P, Kusejko K, Silverberg MJ, Imaz A, Teira R, d'Arminio Monforte A, Zangerle R, Guest JL, et al. Longitudinal trends in causes of death among adults with HIV on antiretroviral therapy in Europe and North America from 1996 to 2020: a collaboration of cohort studies. The Lancet. Hiv. PMID 38280393 DOI: 10.1016/S2352-3018(23)00272-2 |
0.325 |
|
2023 |
Rein SM, Lodi S, Logan RW, Touloumi G, Antoniadou A, Wittkop L, Bonnet F, van Sighem A, van der Valk M, Reiss P, Klein MB, Young J, Jarrin I, d'Arminio Monforte A, Tavelli A, et al. Integrase strand-transfer inhibitor use and cardiovascular events in adults with HIV: an emulation of target trials in the HIV-CAUSAL Collaboration and the Antiretroviral Therapy Cohort Collaboration. The Lancet. Hiv. 10: e723-e732. PMID 37923486 DOI: 10.1016/S2352-3018(23)00233-3 |
0.336 |
|
2023 |
van Paassen P, Dijkstra M, Peay H, Rokx C, Verbon A, Reiss P, Prins J, Henderson GE, Rennie S, Nieuwkerk P, de Bree G. Perceptions of rapid ART initiation among participants of the Netherlands Cohort Study on Acute HIV infection. Aids Research and Human Retroviruses. PMID 37791419 DOI: 10.1089/AID.2022.0169 |
0.339 |
|
2023 |
Mudra Rakshasa-Loots A, Bakewell N, Sharp DJ, Gisslén M, Zetterberg H, Alagaratnam J, Wit FWNM, Kootstra NA, Winston A, Reiss P, Sabin CA, Vera JH. Biomarkers of central and peripheral inflammation mediate the association between HIV and depressive symptoms. Translational Psychiatry. 13: 190. PMID 37280232 DOI: 10.1038/s41398-023-02489-0 |
0.301 |
|
2023 |
Schoepf IC, Esteban-Cantos A, Thorball CW, Rodés B, Reiss P, Rodríguez-Centeno J, Riebensahm C, Braun DL, Marzolini C, Seneghini M, Bernasconi E, Cavassini M, Buvelot H, Thurnheer MC, Kouyos RD, et al. Epigenetic ageing accelerates before antiretroviral therapy and decelerates after viral suppression in people with HIV in Switzerland: a longitudinal study over 17 years. The Lancet. Healthy Longevity. 4: e211-e218. PMID 37148893 DOI: 10.1016/S2666-7568(23)00037-5 |
0.351 |
|
2023 |
Verheij E, Boyd A, Wit FW, Verboeket SO, Verburgh ML, van der Valk M, Schim van der Loeff MF, Reiss P. Long-term evolution of comorbidities and their disease burden in individuals with and without HIV as they age: analysis of the prospective AGEIV cohort study. The Lancet. Hiv. 10: e164-e174. PMID 36774943 DOI: 10.1016/S2352-3018(22)00400-3 |
0.312 |
|
2022 |
Romijnders KAGJ, de Groot L, Vervoort SCJM, Basten M, van Welzen BJ, Kretzschmar ME, Reiss P, Davidovich U, van der Loeff MFS, Rozhnova G. The experienced positive and negative influence of HIV on quality of life of people with HIV and vulnerable to HIV in the Netherlands. Scientific Reports. 12: 21887. PMID 36536038 DOI: 10.1038/s41598-022-25113-5 |
0.339 |
|
2022 |
Prins HAB, Rokx C, Verbon A, van Sighem A, De Bree GJ, Dijkstra M, Prins JM, Reiss P, van Kampen JJA, Van De Vijver DAMC. HIV transmission among acutely infected participants of a Dutch cohort study 2015-2021 is not associated with large, clustered outbreaks. Aids (London, England). PMID 36305171 DOI: 10.1097/QAD.0000000000003416 |
0.321 |
|
2022 |
Verboeket SO, Boyd A, Wit FW, Verheij E, Schim van der Loeff MF, Kootstra N, van der Valk M, van Steenwijk RP, Drummond MB, Kirk GD, Reiss P. Changes in lung function among treated HIV-positive and HIV-negative individuals: analysis of the prospective AGEIV cohort study. The Lancet. Healthy Longevity. 2: e202-e211. PMID 36098121 DOI: 10.1016/S2666-7568(21)00033-7 |
0.325 |
|
2022 |
Blenkinsop A, Monod M, Sighem AV, Pantazis N, Bezemer D, Op de Coul E, van de Laar T, Fraser C, Prins M, Reiss P, de Bree GJ, Ratmann O. Estimating the potential to prevent locally acquired HIV infections in a UNAIDS Fast-Track City, Amsterdam. Elife. 11. PMID 35920649 DOI: 10.7554/eLife.76487 |
0.329 |
|
2022 |
van Paassen P, Dijkstra M, Peay HL, Rokx C, Verbon A, Reiss P, Prins JM, Henderson GE, Rennie S, Nieuwkerk PT, de Bree GJ. Perceptions of HIV cure and willingness to participate in HIV cure-related trials among people enrolled in the Netherlands cohort study on acute HIV infection. Journal of Virus Eradication. 8: 100072. PMID 35769632 DOI: 10.1016/j.jve.2022.100072 |
0.362 |
|
2022 |
Trickey A, Zhang L, Gill MJ, Bonnet F, Burkholder G, Castagna A, Cavassini M, Cichon P, Crane H, Domingo P, Grabar S, Guest J, Obel N, Psichogiou M, Rava M, ... Reiss P, et al. Associations of modern initial antiretroviral drug regimens with all-cause mortality in adults with HIV in Europe and North America: a cohort study. The Lancet. Hiv. 9: e404-e413. PMID 35659335 DOI: 10.1016/S2352-3018(22)00046-7 |
0.334 |
|
2022 |
Romijnders KAGJ, de Groot L, Vervoort SCJM, Basten MGJ, van Welzen BJ, Kretzschmar ME, Reiss P, Davidovich U, Rozhnova G. The perceived impact of an HIV cure by people living with HIV and key populations vulnerable to HIV in the Netherlands: A qualitative study. Journal of Virus Eradication. 8: 100066. PMID 35280938 DOI: 10.1016/j.jve.2022.100066 |
0.348 |
|
2021 |
Verburgh ML, Boyd A, Wit FWNM, Schim van der Loeff MF, van der Valk M, Bakker M, Kootstra NA, van der Hoek L, Reiss P. Similar risk of SARS-CoV-2 infection and similar nucleocapsid antibody levels in people with well-controlled HIV and a comparable cohort of people without HIV. The Journal of Infectious Diseases. PMID 34929034 DOI: 10.1093/infdis/jiab616 |
0.316 |
|
2021 |
Schoepf IC, Thorball CW, Ledergerber B, Kootstra NA, Reiss P, Raffenberg M, Engel T, Braun DL, Hasse B, Thurnheer C, Marzolini C, Seneghini M, Bernasconi E, Cavassini M, Buvelot H, et al. Telomere Length Declines In Persons Living With HIV Before Antiretroviral Therapy Start But Not After Viral Suppression: A Longitudinal Study Over >17 Years. The Journal of Infectious Diseases. PMID 34910812 DOI: 10.1093/infdis/jiab603 |
0.319 |
|
2021 |
Dijkstra M, Prins H, Prins JM, Reiss P, Boucher C, Verbon A, Rokx C, de Bree G. Cohort profile: the Netherlands Cohort Study on Acute HIV infection (NOVA), a prospective cohort study of people with acute or early HIV infection who immediately initiate HIV treatment. Bmj Open. 11: e048582. PMID 34845066 DOI: 10.1136/bmjopen-2020-048582 |
0.36 |
|
2021 |
Bezemer D, Blenkinsop A, Hall M, van Sighem A, Cornelissen M, Wessels E, van Kampen J, van de Laar T, Reiss P, Fraser C, Ratmann O. In-country acquisition of HIV-1 non-B infection within the Netherlands is frequent, but results in limited onward transmission. Aids (London, England). PMID 34618753 DOI: 10.1097/QAD.0000000000003074 |
0.337 |
|
2021 |
Pasternak AO, Vroom J, Kootstra NA, Wit FW, de Bruin M, De Francesco D, Bakker M, Sabin CA, Winston A, Prins JM, Reiss P, Berkhout B. Non-nucleoside reverse transcriptase inhibitor-based combination antiretroviral therapy is associated with lower cell-associated HIV RNA and DNA levels as compared with therapy based on protease inhibitors. Elife. 10. PMID 34387543 DOI: 10.7554/eLife.68174 |
0.304 |
|
2021 |
Lazarus JV, Safreed-Harmon K, Kamarulzaman A, Anderson J, Leite RB, Behrens G, Bekker LG, Bhagani S, Brown D, Brown G, Buchbinder S, Caceres C, Cahn PE, Carrieri P, Caswell G, ... ... Reiss P, et al. Consensus statement on the role of health systems in advancing the long-term well-being of people living with HIV. Nature Communications. 12: 4450. PMID 34272399 DOI: 10.1038/s41467-021-24673-w |
0.307 |
|
2021 |
Atkinson A, Miro JM, Mocroft A, Reiss P, Kirk O, Morlat P, Ghosn J, Stephan C, Mussini C, Antoniadou A, Doerholt K, Girardi E, De Wit S, Kraus D, Zwahlen M, et al. No need for secondary Pneumocystis jirovecii pneumonia prophylaxis in adult people living with HIV from Europe on ART with suppressed viraemia and a CD4 cell count greater than 100 cells/µL. Journal of the International Aids Society. 24: e25726. PMID 34118121 DOI: 10.1002/jia2.25726 |
0.357 |
|
2021 |
Bogers SJ, Schim van der Loeff MF, Davidovich U, Boyd A, van der Valk M, Brinkman K, de Bree GJ, Reiss P, van Bergen JEAM, Geerlings SE. Promoting HIV indicator condition-guided testing in hospital settings (PROTEST 2.0): study protocol for a multicentre interventional study. Bmc Infectious Diseases. 21: 519. PMID 34078315 DOI: 10.1186/s12879-021-06183-8 |
0.308 |
|
2021 |
Davis K, Perez-Guzman P, Hoyer A, Brinks R, Gregg E, Althoff KN, Justice AC, Reiss P, Gregson S, Smit M. Association between HIV infection and hypertension: a global systematic review and meta-analysis of cross-sectional studies. Bmc Medicine. 19: 105. PMID 33980222 DOI: 10.1186/s12916-021-01978-7 |
0.354 |
|
2021 |
Verboeket SO, Boyd A, Wit FW, Verheij E, Schim van der Loeff MF, Kootstra N, van der Valk M, Reiss P. Generally rare but occasionally severe weight gain after switching to an integrase inhibitor in virally suppressed AGEhIV cohort participants. Plos One. 16: e0251205. PMID 33951089 DOI: 10.1371/journal.pone.0251205 |
0.323 |
|
2021 |
Raffenberg M, Engel T, Schoepf IC, Kootstra NA, Reiss P, Braun DL, Thorball CW, Fellay J, Kouyos RD, Ledergerber B, Günthard HF, Tarr PE. Impact of Delaying Antiretroviral Treatment during Primary HIV Infection on Telomere Length. The Journal of Infectious Diseases. PMID 33822976 DOI: 10.1093/infdis/jiab186 |
0.355 |
|
2021 |
Chammartin F, Lodi S, Logan R, Ryom L, Mocroft A, Kirk O, d'Arminio Monforte A, Reiss P, Phillips A, El-Sadr W, Hatleberg CI, Pradier C, Bonnet F, Law M, De Wit S, et al. Risk for Non-AIDS-Defining and AIDS-Defining Cancer of Early Versus Delayed Initiation of Antiretroviral Therapy : A Multinational Prospective Cohort Study. Annals of Internal Medicine. PMID 33721519 DOI: 10.7326/M20-5226 |
0.332 |
|
2021 |
Chan P, Kerr SJ, Kroon E, Colby D, Sacdalan C, Hellmuth J, Reiss P, Vasan S, Ananworanich J, Valcour V, Spudich S, Paul R. Cognitive trajectories after treatment in acute HIV infection. Aids (London, England). PMID 33534200 DOI: 10.1097/QAD.0000000000002831 |
0.308 |
|
2020 |
Verheij E, Wit FW, Verboeket SO, Schim van der Loeff MF, Nellen JF, Reiss P, Kirk GD. Frequency, risk factors and mediators of frailty transitions during long-term follow-up among people with HIV and HIV-negative AGEhIV Cohort participants. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 33105395 DOI: 10.1097/QAI.0000000000002532 |
0.31 |
|
2020 |
Sohn AH, Chalermchockcharoenkit A, Teeraananchai S, Hansudewechakul R, Gatechompol S, Chokephaibulkit K, Dang HLD, Tran DNH, Achalapong J, Teeratakulpisarn N, Thamkhantho M, Phanuphak N, Ananworanich J, Reiss P, Kerr SJ. Increased burden of concordant and sequential anogenital human papillomavirus infections among Asian young adult females with perinatally acquired HIV compared to HIV-negative peers. Sexually Transmitted Diseases. PMID 32976361 DOI: 10.1097/OLQ.0000000000001294 |
0.312 |
|
2020 |
van Welzen BJ, Smit C, Boyd A, Lieveld FI, Mudrikova T, Reiss P, Brouwer AE, Hoepelman AIM, Arends JE. Decreased All-Cause and Liver-Related Mortality Risk in HIV/Hepatitis B Virus Coinfection Coinciding With the Introduction of Tenofovir-Containing Combination Antiretroviral Therapy. Open Forum Infectious Diseases. 7: ofaa226. PMID 32665961 DOI: 10.1093/ofid/ofaa226 |
0.302 |
|
2020 |
Atkinson A, Zwahlen M, Barger D, d'Arminio Monforte A, De Wit S, Ghosn J, Girardi E, Svedhem-Johansson V, Morlat P, Mussini C, Noguera-Julian A, Stephan C, Touloumi G, Kirk O, Mocroft A, ... Reiss P, et al. Withholding primary PcP prophylaxis in virologically suppressed HIV patients: An emulation of a pragmatic trial in COHERE. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 32448894 DOI: 10.1093/cid/ciaa615 |
0.312 |
|
2020 |
Chan P, Goh O, Kroon E, Colby D, Sacdalan C, Pinyakorn S, Prueksakaew P, Reiss P, Ananworanich J, Valcour V, Spudich S, Paul R. Neuropsychiatric outcomes before and after switching to dolutegravir-based therapy in an acute HIV cohort. Aids Research and Therapy. 17: 1. PMID 31907064 DOI: 10.1186/S12981-019-0257-8 |
0.33 |
|
2019 |
de Bree GJ, van Sighem A, Zuilhof W, van Bergen JEAM, Prins M, Heidenrijk M, van der Valk M, Brokx P, Reiss P. Is reaching 90-90-90 enough to end AIDS? Lessons from Amsterdam. Current Opinion in Hiv and Aids. 14: 455-463. PMID 31589173 DOI: 10.1097/COH.0000000000000586 |
0.343 |
|
2019 |
Van den Hof M, Ter Haar AM, Scherpbier HJ, van der Lee JH, Reiss P, Wit FWNM, Oostrom KJ, Pajkrt D. Neurocognitive development in perinatally HIV-infected adolescents on long-term treatment compared to healthy matched controls: a longitudinal study. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 31106812 DOI: 10.1093/cid/ciz386 |
0.311 |
|
2019 |
Caniglia EC, Robins JM, Cain LE, Sabin C, Logan R, Abgrall S, Mugavero MJ, Hernández-Díaz S, Meyer L, Seng R, Drozd DR, Seage Iii GR, Bonnet F, Le Marec F, Moore RD, ... Reiss P, et al. Emulating a trial of joint dynamic strategies: An application to monitoring and treatment of HIV-positive individuals. Statistics in Medicine. PMID 30883859 DOI: 10.1002/Sim.8120 |
0.33 |
|
2019 |
Toxopeus DCM, Pell CL, Westrhenen NB, Smit C, Wit FWNM, Ondoa P, Reiss P, Boender TS. Compliance with laboratory monitoring guidelines in outpatient HIV care: a qualitative study in the Netherlands. Aids Care. 1-8. PMID 30602294 DOI: 10.1080/09540121.2018.1563280 |
0.31 |
|
2018 |
Verboeket SO, Wit FW, Kirk GD, Drummond MB, van Steenwijk RP, van Zoest RA, Nellen JF, van der Loeff MFS, Reiss P. Reduced Forced Vital Capacity among HIV-infected middle-aged individuals. The Journal of Infectious Diseases. PMID 30418599 DOI: 10.1093/infdis/jiy653 |
0.337 |
|
2018 |
De Francesco D, Wit FW, Bürkle A, Oehlke S, Kootstra NA, Winston A, Franceschi C, Garagnani P, Pirazzini C, Libert C, Grune T, Weber D, Jansen EHJM, Sabin CA, Reiss P, et al. Do people living with HIV experience greater age advancement than their HIV-negative counterparts? Aids (London, England). PMID 30325781 DOI: 10.1097/QAD.0000000000002063 |
0.328 |
|
2018 |
Boender TS, Smit C, Sighem AV, Bezemer D, Ester CJ, Zaheri S, Wit FWNM, Reiss P. AIDS Therapy Evaluation in the Netherlands (ATHENA) national observational HIV cohort: cohort profile. Bmj Open. 8: e022516. PMID 30249631 DOI: 10.1136/bmjopen-2018-022516 |
0.365 |
|
2018 |
Verheij E, van Zoest RA, van der Valk M, Wit FW, Reiss P. [The older HIV patient in the Netherlands]. Nederlands Tijdschrift Voor Geneeskunde. 162. PMID 30040311 |
0.355 |
|
2018 |
Dijkstra M, van Lunsen RHW, Kooij KW, Davidovich U, van Zoest RA, Wit FWMN, Prins M, Reiss P, Schim van der Loeff MF. HIV-1 status is independently associated with decreased erectile function among middle-aged MSM in the era of combination antiretroviral therapy. Aids (London, England). 32: 1137-1146. PMID 29746318 DOI: 10.1097/QAD.0000000000001800 |
0.317 |
|
2018 |
Kroeze S, Ondoa P, Kityo CM, Siwale M, Akanmu S, Wellington M, de Jager M, Ive P, Mandaliya K, Stevens W, Boender TS, de Pundert ME, Sigaloff KCE, Reiss P, Wit FW, et al. Suboptimal immune recovery during antiretroviral therapy with sustained HIV suppression in sub-Saharan Africa. Aids (London, England). PMID 29547445 DOI: 10.1097/QAD.0000000000001801 |
0.313 |
|
2018 |
Cohen S, Innes S, Geelen SPM, Wells JCK, Smit C, Wolfs TFW, van Eck-Smit BLF, Kuijpers TW, Reiss P, Scherpbier HJ, Pajkrt D, Bunders MJ. Correction: Long-Term Changes of Subcutaneous Fat Mass in HIV-Infected Children on Antiretroviral Therapy: A Retrospective Analysis of Longitudinal Data from Two Pediatric HIV-Cohorts. Plos One. 13: e0190726. PMID 29293642 DOI: 10.1371/journal.pone.0190726 |
0.312 |
|
2017 |
Mocroft A, Laut K, Reiss P, Gatell J, Ormaasen V, Cavassini M, Hadziosmanovic V, Mansinho K, Pradier C, Vasylyev M, Mitsura V, Vandekerckhove L, Ostergaard L, Clarke A, Degen O, et al. Where is the greatest impact of uncontrolled HIV infection on AIDS and non-AIDS events in HIV? Aids (London, England). PMID 29112060 DOI: 10.1097/QAD.0000000000001684 |
0.346 |
|
2017 |
Van Zoest RA, Underwood J, De Francesco D, Sabin CA, Cole JH, Wit FW, Caan MWA, Kootstra NA, Fuchs D, Zetterberg H, Majoie CBLM, Portegies P, Winston A, Sharp DJ, Gisslén M, ... Reiss P, et al. Structural brain abnormalities in successfully treated HIV infection: associations with disease and cerebrospinal fluid biomarkers. The Journal of Infectious Diseases. PMID 29069436 DOI: 10.1093/Infdis/Jix553 |
0.306 |
|
2017 |
Booiman T, Wit FW, Girigorie AF, Maurer I, De Francesco D, Sabin CA, Harskamp AM, Prins M, Franceschi C, Deeks SG, Winston A, Reiss P, Kootstra NA. Terminal differentiation of T cells is strongly associated with CMV infection and increased in HIV-positive individuals on ART and lifestyle matched controls. Plos One. 12: e0183357. PMID 28806406 DOI: 10.1371/journal.pone.0183357 |
0.347 |
|
2017 |
van Zoest RA, van den Born BH, Reiss P. Hypertension in people living with HIV. Current Opinion in Hiv and Aids. PMID 28787286 DOI: 10.1097/COH.0000000000000406 |
0.302 |
|
2017 |
Lodi S, Costagliola D, Sabin C, Amo JD, Logan R, Abgrall S, Reiss P, van Sighem A, Jose S, Blanco JR, Hernando V, Bucher HC, Kovari H, Segura F, Ambrosioni J, et al. Effect of immediate initiation of antiretroviral treatment in HIV-positive individuals aged 50 years or older. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 28746165 DOI: 10.1097/Qai.0000000000001498 |
0.32 |
|
2017 |
van Zoest RA, van der Valk M, Wit FW, Vaartjes I, Kooij KW, Hovius JW, Prins M, Reiss P. Suboptimal primary and secondary cardiovascular disease prevention in HIV-positive individuals on antiretroviral therapy. European Journal of Preventive Cardiology. 2047487317714350. PMID 28578613 DOI: 10.1177/2047487317714350 |
0.344 |
|
2017 |
Langebeek N, Kooij KW, Wit FW, Stolte IG, Sprangers MAG, Reiss P, Nieuwkerk PT. Impact of comorbidity and ageing on health-related quality of life in HIV-positive and HIV-negative individuals. Aids (London, England). 31: 1471-1481. PMID 28574965 DOI: 10.1097/QAD.0000000000001511 |
0.32 |
|
2017 |
Sabin CA, Reiss P. Epidemiology of ageing with HIV: what can we learn from cohorts? Aids (London, England). 31: S121-S128. PMID 28471942 DOI: 10.1097/QAD.0000000000001374 |
0.357 |
|
2017 |
Caniglia EC, Cain LE, Sabin CA, Robins JM, Logan R, Abgrall S, Mugavero MJ, Hernández-Díaz S, Meyer L, Seng R, Drozd DR, Seage GR, Bonnet F, Dabis F, Moore RD, ... Reiss P, et al. Comparison of dynamic monitoring strategies based on CD4 cell counts in virally suppressed, HIV-positive individuals on combination antiretroviral therapy in high-income countries: a prospective, observational study. The Lancet. Hiv. PMID 28411091 DOI: 10.1016/S2352-3018(17)30043-7 |
0.322 |
|
2017 |
Chereau F, Madec Y, Sabin C, Obel N, Ruiz-Mateos E, Chrysos G, Fidler S, Lehmann C, Zangerle R, Wittkop L, Reiss P, Hamouda O, Estrada Perez V, Leal M, Mocroft A, et al. Impact of CD4 and CD8 dynamics and viral rebounds on loss of virological control in HIV controllers. Plos One. 12: e0173893. PMID 28380038 DOI: 10.1371/journal.pone.0173893 |
0.327 |
|
2017 |
Su T, Mutsaerts HJ, Caan MW, Wit FW, Schouten J, Geurtsen GJ, Sharp DJ, Prins M, Richard E, Portegies P, Reiss P, Majoie CB. Cerebral blood flow and cognitive function in HIV-infected men with sustained suppressed viremia on combination antiretroviral therapy. Aids (London, England). PMID 28121708 DOI: 10.1097/Qad.0000000000001414 |
0.341 |
|
2016 |
Kooij KW, Wit FW, Booiman T, van der Valk M, Schim van der Loeff MF, Kootstra NA, Reiss P. Cigarette smoking and inflammation, monocyte activation and coagulation in HIV-infected individuals on antiretroviral therapy compared to uninfected individuals. The Journal of Infectious Diseases. PMID 27683822 DOI: 10.1093/infdis/jiw459 |
0.302 |
|
2016 |
Kooij KW, Schouten J, Wit FW, van der Valk M, Kootstra NA, Stolte IG, van der Meer JT, Prins M, Grobbee DE, van den Born BJ, Reiss P. Difference in Aortic Stiffness Between Treated Middle-Aged HIV Type 1-Infected and Uninfected Individuals Largely Explained by Traditional Cardiovascular Risk Factors, With an Additional Contribution of Prior Advanced Immunodeficiency. Journal of Acquired Immune Deficiency Syndromes (1999). 73: 55-62. PMID 27513572 DOI: 10.1097/QAI.0000000000001024 |
0.357 |
|
2016 |
Engelhard EA, Smit C, Vervoort SC, Smit PJ, Nieuwkerk PT, Kroon FP, Reiss P, Brinkman K, Geerlings SE. Patients' Willingness to Take Multiple-Tablet Antiretroviral Therapy Regimens for Treatment of HIV. Drugs - Real World Outcomes. 3: 223-230. PMID 27398301 DOI: 10.1007/s40801-016-0070-9 |
0.326 |
|
2016 |
Su T, Wit FW, Caan MW, Schouten J, Prins M, Geurtsen GJ, Cole JH, Sharp DJ, Richard E, Reneman L, Portegies P, Reiss P, Majoie CB. White matter hyperintensities in relation to cognition in HIV-infected men with sustained suppressed viral load on cART. Aids (London, England). PMID 27149087 DOI: 10.1097/Qad.0000000000001133 |
0.31 |
|
2016 |
van Zoest RA, Wit FW, Kooij KW, van der Valk M, Schouten J, Kootstra NA, Wiersinga WJ, Prins M, van den Born BH, Reiss P. Higher prevalence of hypertension in HIV-1-infected patients on combination antiretroviral therapy is associated with changes in body composition and prior stavudine exposure. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 27143668 DOI: 10.1093/cid/ciw285 |
0.352 |
|
2016 |
Cobos Jiménez V, Wit FW, Joerink M, Maurer I, Harskamp AM, Schouten J, Prins M, van Leeuwen EM, Booiman T, Deeks SG, Reiss P, Kootstra NA. T-cell activation independently associates with immune senescence in long-term antiretroviral drug-treated HIV-1-infected individuals. The Journal of Infectious Diseases. PMID 27073222 DOI: 10.1093/infdis/jiw146 |
0.349 |
|
2016 |
Demirkaya N, Wit FW, van Den Berg TJ, Kooij KW, Prins M, Schlingemann RO, Abramoff MD, Reiss P, Verbraak FD. HIV-Associated Neuroretinal Disorder in Patients With Well-Suppressed HIV-Infection: A Comparative Cohort Study. Investigative Ophthalmology & Visual Science. 57: 1388-97. PMID 27018841 DOI: 10.1167/Iovs.15-18537 |
0.364 |
|
2016 |
Caniglia EC, Sabin C, Robins JM, Logan R, Cain LE, Abgrall S, Mugavero MJ, Hernandez-Diaz S, Meyer L, Seng R, Drozd DR, Seage GR, Bonnet F, Dabis F, Moore RR, ... Reiss P, et al. When to Monitor CD4 Cell Count and HIV RNA to Reduce Mortality and AIDS-Defining Illness in Virologically Suppressed HIV-Positive Persons on Antiretroviral Therapy in High-Income Countries: A Prospective Observational Study. Journal of Acquired Immune Deficiency Syndromes (1999). 72: 214-221. PMID 26895294 DOI: 10.1097/Qai.0000000000000956 |
0.342 |
|
2016 |
Schouten J, Su T, Wit FW, Kootstra NA, Caan MW, Geurtsen GJ, Schmand BA, Stolte IG, Prins M, Majoie CB, Portegies P, Reiss P. Determinants of reduced cognitive performance in HIV-1-infected middle-aged men on combination antiretroviral therapy. Aids (London, England). PMID 26752277 DOI: 10.1097/Qad.0000000000001017 |
0.309 |
|
2016 |
Möller LM, Brands R, Sluiter JK, Schouten J, Wit FW, Reiss P, Prins M, Stolte IG. Prevalence and determinants of insufficient work ability in older HIV-positive and HIV-negative workers. International Archives of Occupational and Environmental Health. 89: 699-709. PMID 26747456 DOI: 10.1007/s00420-015-1108-0 |
0.323 |
|
2016 |
Ratmann O, van Sighem A, Bezemer D, Gavryushkina A, Jurriaans S, Wensing A, de Wolf F, Reiss P, Fraser C. Sources of HIV infection among men having sex with men and implications for prevention. Science Translational Medicine. 8: 320ra2. PMID 26738795 DOI: 10.1126/scitranslmed.aad1863 |
0.309 |
|
2016 |
Op de Coul EL, van Sighem A, Brinkman K, van Benthem BH, van der Ende ME, Geerlings S, Reiss P. Factors associated with presenting late or with advanced HIV disease in the Netherlands, 1996-2014: results from a national observational cohort. Bmj Open. 6: e009688. PMID 26729389 DOI: 10.1136/bmjopen-2015-009688 |
0.363 |
|
2016 |
Su T, Caan MW, Wit FW, Schouten J, Geurtsen GJ, Cole JH, Sharp DJ, Vos FM, Prins M, Portegies P, Reiss P, Majoie CB. White matter structure alterations in HIV-1-infected men with sustained suppression of viraemia on treatment. Aids (London, England). 30: 311-22. PMID 26691551 DOI: 10.1097/Qad.0000000000000945 |
0.334 |
|
2016 |
Engelhard EA, Smit C, Van Sighem A, Reiss P, Nieuwkerk PT, Kroon FP, Brinkman K, Geerlings SE. Impact of HIV care facility characteristics on the cascade of care in HIV-infected patients in the Netherlands. Aids (London, England). 30: 301-10. PMID 26691550 DOI: 10.1097/QAD.0000000000000938 |
0.339 |
|
2016 |
Kooij KW, Wit FW, Schouten J, van der Valk M, Godfried MH, Stolte IG, Prins M, Falutz J, Reiss P. HIV infection is independently associated with frailty in middle-aged HIV type 1-infected individuals compared with similar but uninfected controls. Aids (London, England). 30: 241-50. PMID 26684821 DOI: 10.1097/QAD.0000000000000910 |
0.322 |
|
2016 |
May MT, Gill MJ, Wittkop L, Klein M, Sabin C, Harrigan PR, Dunn D, Vehreschild JJ, Rubio R, Mocroft A, Cavassini M, ... Reiss P, et al. Mortality of treated HIV-1 positive individuals according to viral subtype in Europe and Canada: collaborative cohort analysis. Aids (London, England). 30: 503-13. PMID 26562844 DOI: 10.1097/Qad.0000000000000941 |
0.344 |
|
2015 |
Pasternak AO, DeMaster LK, Kootstra NA, Reiss P, O'Doherty U, Berkhout B. Minor Contribution of Chimeric Host-HIV Readthrough Transcripts to the Level of HIV Cell-Associated gag RNA. Journal of Virology. 90: 1148-51. PMID 26559833 DOI: 10.1128/Jvi.02597-15 |
0.326 |
|
2015 |
Lodi S, Phillips A, Logan R, Olson A, Costagliola D, Abgrall S, van Sighem A, Reiss P, Miró JM, Ferrer E, Justice A, Gandhi N, Bucher HC, Furrer H, Moreno S, et al. Comparative effectiveness of immediate antiretroviral therapy versus CD4-based initiation in HIV-positive individuals in high-income countries: observational cohort study. The Lancet. Hiv. 2: e335-43. PMID 26423376 DOI: 10.1016/S2352-3018(15)00108-3 |
0.325 |
|
2015 |
Cohen S, Ter Stege JA, Weijsenfeld AM, van der Plas A, Kuijpers TW, Reiss P, Scherpbier HJ, Haverman L, Pajkrt D. Health-related quality of life in perinatally HIV-infected children in the Netherlands. Aids Care. 27: 1279-88. PMID 26272357 DOI: 10.1080/09540121.2015.1050986 |
0.301 |
|
2015 |
Cohen S, Innes S, Geelen SP, Wells JC, Smit C, Wolfs TF, van Eck-Smit BL, Kuijpers TW, Reiss P, Scherpbier HJ, Pajkrt D, Bunders MJ. Long-Term Changes of Subcutaneous Fat Mass in HIV-Infected Children on Antiretroviral Therapy: A Retrospective Analysis of Longitudinal Data from Two Pediatric HIV-Cohorts. Plos One. 10: e0120927. PMID 26148119 DOI: 10.1371/journal.pone.0120927 |
0.314 |
|
2015 |
Bollen P, Reiss P, Schapiro J, Burger D. Clinical pharmacokinetics and pharmacodynamics of dolutegravir used as a single tablet regimen for the treatment of HIV-1 infection. Expert Opinion On Drug Safety. 14: 1457-72. PMID 26134478 DOI: 10.1517/14740338.2015.1059818 |
0.309 |
|
2015 |
Demirkaya N, Cohen S, Wit FW, Abramoff MD, Schlingemann RO, Kuijpers TW, Reiss P, Pajkrt D, Verbraak FD. Retinal Structure and Function in Perinatally HIV-Infected and cART-Treated Children: A Matched Case-Control Study. Investigative Ophthalmology & Visual Science. 56: 3945-54. PMID 26087360 DOI: 10.1167/Iovs.15-16855 |
0.308 |
|
2015 |
Friis-Møller N, Ryom L, Smith C, Weber R, Reiss P, Dabis F, De Wit S, Monforte AD, Kirk O, Fontas E, Sabin C, Phillips A, Lundgren J, Law M. An updated prediction model of the global risk of cardiovascular disease in HIV-positive persons: The Data-collection on Adverse Effects of Anti-HIV Drugs (D:A:D) study. European Journal of Preventive Cardiology. PMID 25882821 DOI: 10.1177/2047487315579291 |
0.301 |
|
2015 |
Schoffelen AF, Smit C, van Lelyveld SF, Vogt L, Bauer MP, Reiss P, Hoepelman AI, Barth RE. Diminished Impact of Ethnicity as a Risk Factor for Chronic Kidney Disease in the Current HIV Treatment Era. The Journal of Infectious Diseases. 212: 264-74. PMID 25601941 DOI: 10.1093/infdis/jiv026 |
0.309 |
|
2015 |
Cohen S, Ter Stege JA, Geurtsen GJ, Scherpbier HJ, Kuijpers TW, Reiss P, Schmand B, Pajkrt D. Poorer cognitive performance in perinatally HIV-infected children versus healthy socioeconomically matched controls. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 60: 1111-9. PMID 25516183 DOI: 10.1093/cid/ciu1144 |
0.301 |
|
2015 |
Helleberg M, May MT, Ingle SM, Dabis F, Reiss P, Fätkenheuer G, Costagliola D, d'Arminio A, Cavassini M, Smith C, Justice AC, Gill J, Sterne JA, Obel N. Smoking and life expectancy among HIV-infected individuals on antiretroviral therapy in Europe and North America. Aids (London, England). 29: 221-9. PMID 25426809 DOI: 10.1097/Qad.0000000000000540 |
0.352 |
|
2015 |
Kooij KW, Wit FW, Bisschop PH, Schouten J, Stolte IG, Prins M, van der Valk M, Prins JM, van Eck-Smit BL, Lips P, Reiss P. Low bone mineral density in patients with well-suppressed HIV infection: association with body weight, smoking, and prior advanced HIV disease. The Journal of Infectious Diseases. 211: 539-48. PMID 25180239 DOI: 10.1093/infdis/jiu499 |
0.356 |
|
2014 |
Zanni MV, Schouten J, Grinspoon SK, Reiss P. Risk of coronary heart disease in patients with HIV infection. Nature Reviews. Cardiology. 11: 728-41. PMID 25331088 DOI: 10.1038/nrcardio.2014.167 |
0.339 |
|
2014 |
Schouten J, Wit FW, Stolte IG, Kootstra NA, van der Valk M, Geerlings SE, Prins M, Reiss P. Cross-sectional comparison of the prevalence of age-associated comorbidities and their risk factors between HIV-infected and uninfected individuals: the AGEhIV cohort study. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 59: 1787-97. PMID 25182245 DOI: 10.1093/cid/ciu701 |
0.303 |
|
2014 |
Smith CJ, Ryom L, Weber R, Morlat P, Pradier C, Reiss P, Kowalska JD, de Wit S, Law M, el Sadr W, Kirk O, Friis-Moller N, Monforte Ad, Phillips AN, Sabin CA, et al. Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration. Lancet. 384: 241-8. PMID 25042234 DOI: 10.1016/S0140-6736(14)60604-8 |
0.304 |
|
2014 |
Günthard HF, Aberg JA, Eron JJ, Hoy JF, Telenti A, Benson CA, Burger DM, Cahn P, Gallant JE, Glesby MJ, Reiss P, Saag MS, Thomas DL, Jacobsen DM, Volberding PA, et al. Antiretroviral treatment of adult HIV infection: 2014 recommendations of the International Antiviral Society-USA Panel. Jama. 312: 410-25. PMID 25038359 DOI: 10.1001/jama.2014.8722 |
0.311 |
|
2013 |
Mutwa PR, Van Nuil JI, Asiimwe-Kateera B, Kestelyn E, Vyankandondera J, Pool R, Ruhirimbura J, Kanakuze C, Reiss P, Geelen S, van de Wijgert J, Boer KR. Living situation affects adherence to combination antiretroviral therapy in HIV-infected adolescents in Rwanda: a qualitative study. Plos One. 8: e60073. PMID 23573232 DOI: 10.1371/journal.pone.0060073 |
0.304 |
|
2013 |
Rotger M, Glass TR, Junier T, Lundgren J, Neaton JD, Poloni ES, van 't Wout AB, Lubomirov R, Colombo S, Martinez R, Rauch A, Günthard HF, Neuhaus J, Wentworth D, van Manen D, ... ... Reiss P, et al. Contribution of genetic background, traditional risk factors, and HIV-related factors to coronary artery disease events in HIV-positive persons. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 57: 112-21. PMID 23532479 DOI: 10.1093/Cid/Cit196 |
0.321 |
|
2013 |
Grijsen ML, Vrouenraets SM, Wit FW, Stolte IG, Prins M, Lips P, Reiss P, Prins JM. Low bone mineral density, regardless of HIV status, in men who have sex with men. The Journal of Infectious Diseases. 207: 386-91. PMID 23148289 DOI: 10.1093/infdis/jis687 |
0.333 |
|
2012 |
Petoumenos K, Worm SW, Fontas E, Weber R, De Wit S, Bruyand M, Reiss P, El-Sadr W, Monforte AD, Friis-Møller N, Lundgren JD, Law MG. Predicting the short-term risk of diabetes in HIV-positive patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study. Journal of the International Aids Society. 15: 17426. PMID 23078769 DOI: 10.7448/IAS.15.2.17426 |
0.328 |
|
2012 |
Thompson MA, Aberg JA, Hoy JF, Telenti A, Benson C, Cahn P, Eron JJ, Günthard HF, Hammer SM, Reiss P, Richman DD, Rizzardini G, Thomas DL, Jacobsen DM, Volberding PA. Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society-USA panel. Jama. 308: 387-402. PMID 22820792 DOI: 10.1001/jama.2012.7961 |
0.322 |
|
2012 |
Young J, Psichogiou M, Meyer L, Ayayi S, Grabar S, Raffi F, Reiss P, Gazzard B, Sharland M, Gutierrez F, Obel N, Kirk O, Miro JM, Furrer H, et al. CD4 cell count and the risk of AIDS or death in HIV-Infected adults on combination antiretroviral therapy with a suppressed viral load: a longitudinal cohort study from COHERE. Plos Medicine. 9: e1001194. PMID 22448150 DOI: 10.1371/journal.pmed.1001194 |
0.323 |
|
2011 |
Kesselring A, Gras L, Smit C, van Twillert G, Verbon A, de Wolf F, Reiss P, Wit F. Immunodeficiency as a risk factor for non-AIDS-defining malignancies in HIV-1-infected patients receiving combination antiretroviral therapy. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 52: 1458-65. PMID 21628488 DOI: 10.1093/cid/cir207 |
0.338 |
|
2011 |
Schouten J, Cinque P, Gisslen M, Reiss P, Portegies P. HIV-1 infection and cognitive impairment in the cART era: a review. Aids (London, England). 25: 561-75. PMID 21160410 DOI: 10.1097/Qad.0B013E3283437F9A |
0.323 |
|
2010 |
Kesselring AM, Gras L, Wit FW, Smit C, Geerlings SE, Mulder JW, Schreij G, Sprenger HG, Reiss P, de Wolf F. Immune restoration and onset of new AIDS-defining events with combination antiretroviral therapy in HIV type-1-infected immigrants in the Netherlands. Antiviral Therapy. 15: 871-9. PMID 20834099 DOI: 10.3851/IMP1638 |
0.348 |
|
2010 |
Thompson MA, Aberg JA, Cahn P, Montaner JS, Rizzardini G, Telenti A, Gatell JM, Günthard HF, Hammer SM, Hirsch MS, Jacobsen DM, Reiss P, Richman DD, Volberding PA, Yeni P, et al. Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA panel. Jama. 304: 321-33. PMID 20639566 DOI: 10.1001/Jama.2010.1004 |
0.338 |
|
2010 |
Zhang S, van Sighem A, Gras L, Reiss P, Smit C, Kroon F, Jurriaans S, Prins J, Lange J, de Wolf F. Clinical significance of transient HIV type-1 viraemia and treatment interruptions during suppressive antiretroviral treatment. Antiviral Therapy. 15: 555-62. PMID 20587848 DOI: 10.3851/Imp1564 |
0.305 |
|
2010 |
Friis-Møller N, Thiébaut R, Reiss P, Weber R, Monforte AD, De Wit S, El-Sadr W, Fontas E, Worm S, Kirk O, Phillips A, Sabin CA, Lundgren JD, Law MG. Predicting the risk of cardiovascular disease in HIV-infected patients: the data collection on adverse effects of anti-HIV drugs study. European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups On Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology. 17: 491-501. PMID 20543702 DOI: 10.1097/Hjr.0B013E328336A150 |
0.32 |
|
2010 |
Mocroft A, Kirk O, Reiss P, De Wit S, Sedlacek D, Beniowski M, Gatell J, Phillips AN, Ledergerber B, Lundgren JD. Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patients. Aids (London, England). 24: 1667-78. PMID 20523203 DOI: 10.1097/QAD.0b013e328339fe53 |
0.32 |
|
2010 |
van Sighem AI, Gras LA, Reiss P, Brinkman K, de Wolf F. Life expectancy of recently diagnosed asymptomatic HIV-infected patients approaches that of uninfected individuals. Aids (London, England). 24: 1527-35. PMID 20467289 DOI: 10.1097/QAD.0b013e32833a3946 |
0.308 |
|
2010 |
Lodwick R, Costagliola D, Reiss P, Torti C, Teira R, Dorrucci M, Ledergerber B, Mocroft A, Podzamczer D, Cozzi-Lepri A, Obel N, Masquelier B, Staszewski S, GarcÃa F, et al. Triple-class virologic failure in HIV-infected patients undergoing antiretroviral therapy for up to 10 years. Archives of Internal Medicine. 170: 410-9. PMID 20212176 DOI: 10.1001/archinternmed.2009.472 |
0.318 |
|
2009 |
van Leuven SI, Sankatsing RR, Vermeulen JN, Kastelein JJ, Reiss P, Stroes ES. Atherosclerotic vascular disease in HIV: it is not just antiretroviral therapy that hurts the heart! Current Opinion in Hiv and Aids. 2: 324-31. PMID 19372907 DOI: 10.1097/COH.0b013e3281e38a98 |
0.343 |
|
2008 |
Harris RJ, Sterne JA, Abgrall S, Dabis F, Reiss P, Saag M, Phillips AN, Chêne G, Gill JM, Justice AC, Rockstroh J, Sabin CA, Mocroft A, Bucher HC, Hogg RS, et al. Prognostic importance of anaemia in HIV type-1-infected patients starting antiretroviral therapy: collaborative analysis of prospective cohort studies. Antiviral Therapy. 13: 959-67. PMID 19195321 DOI: 10.7892/Boris.27764 |
0.339 |
|
2008 |
Hammer SM, Eron JJ, Reiss P, Schooley RT, Thompson MA, Walmsley S, Cahn P, Fischl MA, Gatell JM, Hirsch MS, Jacobsen DM, Montaner JS, Richman DD, Yeni PG, Volberding PA, et al. Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel. Jama. 300: 555-70. PMID 18677028 DOI: 10.1001/jama.300.5.555 |
0.319 |
|
2008 |
Grunfeld C, Kotler DP, Arnett DK, Falutz JM, Haffner SM, Hruz P, Masur H, Meigs JB, Mulligan K, Reiss P, Samaras K. Contribution of metabolic and anthropometric abnormalities to cardiovascular disease risk factors. Circulation. 118: e20-8. PMID 18566314 DOI: 10.1161/Circulationaha.107.189623 |
0.341 |
|
2008 |
De Wit S, Sabin CA, Weber R, Worm SW, Reiss P, Cazanave C, El-Sadr W, Monforte Ad, Fontas E, Law MG, Friis-Møller N, Phillips A. Incidence and risk factors for new-onset diabetes in HIV-infected patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study. Diabetes Care. 31: 1224-9. PMID 18268071 DOI: 10.2337/dc07-2013 |
0.32 |
|
2007 |
Ceccherini-Silberstein F, Cozzi-Lepri A, Ruiz L, Mocroft A, Phillips AN, Olsen CH, Gatell JM, Gunthard HF, Reiss P, Perno CF, Clotet B, Lundgren JD. Impact of HIV-1 reverse transcriptase polymorphism F214L on virological response to thymidine analogue-based regimens in antiretroviral therapy (ART)-naive and ART-experienced patients. The Journal of Infectious Diseases. 196: 1180-90. PMID 17955437 DOI: 10.1086/521678 |
0.318 |
|
2007 |
May M, Sterne JA, Sabin C, Costagliola D, Justice AC, Thiébaut R, Gill J, Phillips A, Reiss P, Hogg R, Ledergerber B, D'Arminio Monforte A, Schmeisser N, Staszewski S, Egger M, et al. Prognosis of HIV-1-infected patients up to 5 years after initiation of HAART: collaborative analysis of prospective studies. Aids (London, England). 21: 1185-97. PMID 17502729 DOI: 10.1097/QAD.0b013e328133f285 |
0.34 |
|
2006 |
Boyd MA, Srasuebkul P, Khongphattanayothin M, Ruxrungtham K, Hassink EA, Duncombe CJ, Ubolyam S, Burger DM, Reiss P, Stek M, Lange J, Cooper DA, Phanuphak P. Boosted versus unboosted indinavir with zidovudine and lamivudine in nucleoside pre-treated patients: a randomized, open-label trial with 112 weeks of follow-up (HIV-NAT 005). Antiviral Therapy. 11: 223-32. PMID 16640103 |
0.312 |
|
2005 |
Mocroft A, Soriano V, Rockstroh J, Reiss P, Kirk O, de Wit S, Gatell J, Clotet B, Phillips AN, Lundgren JD. Is there evidence for an increase in the death rate from liver-related disease in patients with HIV? Aids (London, England). 19: 2117-25. PMID 16284461 |
0.312 |
|
2005 |
Cossarizza A, Reiss P. Mitochondria, HIV infection and its treatment: where do we go from here? Antiviral Therapy. M1-2. PMID 16152701 |
0.32 |
|
2005 |
van der Kuyl AC, Kozaczynska K, van den Burg R, Zorgdrager F, Back N, Jurriaans S, Berkhout B, Reiss P, Cornelissen M. Triple HIV-1 infection. The New England Journal of Medicine. 352: 2557-9. PMID 15958817 DOI: 10.1056/NEJM200506163522420 |
0.338 |
|
2005 |
Casula M, Bosboom-Dobbelaer I, Smolders K, Otto S, Bakker M, de Baar MP, Reiss P, de Ronde A. Infection with HIV-1 induces a decrease in mtDNA. The Journal of Infectious Diseases. 191: 1468-71. PMID 15809905 DOI: 10.1086/429412 |
0.319 |
|
2004 |
Mocroft A, Gatell J, Reiss P, Ledergerber B, Kirk O, Vella S, Blaxhult A, Phillips AN, Lundgren J. Causes of death in HIV infection: The key determinant to define the clinical response to anti-HIV therapy Aids. 18: 2333-2337. PMID 15577550 DOI: 10.1097/00002030-200411190-00018 |
0.349 |
|
2004 |
van Sighem AI, van de Wiel MA, Ghani AC, Jambroes M, Reiss P, Gyssens IC, Brinkman K, Lange JM, de Wolf F. Mortality and progression to AIDS after starting highly active antiretroviral therapy. Aids (London, England). 17: 2227-36. PMID 14523280 DOI: 10.1097/00002030-200310170-00011 |
0.313 |
|
2003 |
Friis-Møller N, Weber R, Reiss P, Thiébaut R, Kirk O, d'Arminio Monforte A, Pradier C, Morfeldt L, Mateu S, Law M, El-Sadr W, De Wit S, Sabin CA, Phillips AN, Lundgren JD, et al. Cardiovascular disease risk factors in HIV patients--association with antiretroviral therapy. Results from the DAD study. Aids (London, England). 17: 1179-93. PMID 12819520 DOI: 10.1097/01.aids.0000060358.78202.c1 |
0.311 |
|
2003 |
van Leeuwen R, Katlama C, Murphy RL, Squires K, Gatell J, Horban A, Clotet B, Staszewski S, van Eeden A, Clumeck N, Moroni M, Pavia AT, Schmidt RE, Gonzalez-Lahoz J, Montaner J, ... ... Reiss P, et al. A randomized trial to study first-line combination therapy with or without a protease inhibitor in HIV-1-infected patients. Aids (London, England). 17: 987-99. PMID 12700448 DOI: 10.1097/00002030-200305020-00007 |
0.3 |
|
2003 |
Arnaiz JA, Mallolas J, Podzamczer D, Gerstoft J, Lundgren JD, Cahn P, Fätkenheuer G, D'Arminio-Monforte A, Casiró A, Reiss P, Burger DM, Stek M, Gatell JM. Continued indinavir versus switching to indinavir/ritonavir in HIV-infected patients with suppressed viral load. Aids (London, England). 17: 831-40. PMID 12660530 DOI: 10.1097/00002030-200304110-00008 |
0.304 |
|
2003 |
Negredo E, Ribalta J, Paredes R, Ferré R, Sirera G, Ruiz L, Salazar J, Reiss P, Masana L, Clotet B. Reversal of atherogenic lipoprotein profile in HIV-1 infected patients with lipodystrophy after replacing protease inhibitors by nevirapine. Aids (London, England). 16: 1383-9. PMID 12131215 DOI: 10.1097/00002030-200207050-00010 |
0.308 |
|
2002 |
Kirk O, Reiss P, Uberti-Foppa C, Bickel M, Gerstoft J, Pradier C, Wit FW, Ledergerber B, Lundgren JD, Furrer H. Safe interruption of maintenance therapy against previous infection with four common HIV-associated opportunistic pathogens during potent antiretroviral therapy. Annals of Internal Medicine. 137: 239-50. PMID 12186514 DOI: 10.7326/0003-4819-137-4-200208200-00008 |
0.303 |
|
Show low-probability matches. |